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Background
Country-specific patient rare disease registries are rarely
used to make international comparisons because of pro-
tocol discrepancies in data collation. Here, we attempt
to overcome this limitation by using the inherited dis-
ease Cystic Fibrosis (CF) as a paradigm. CF provides a
good example because its common form (homozygous
F508del-CFTR) occurs across all European social strata
appearing frequently but randomly thus providing an
opportunity to measure health outcomes.
Methods
Country-specific CF Registries were combined cross-sec-
tionally using a common data protocol (http://www.
eurocarecf.eu) to compare patient demographics
between the European Union (EU) and non-EU coun-
tries using EU membership in 2003 as a reference base.
We tested the hypothesis that the nine-fold higher
resources within the EU would translate into better
outcomes.
Findings
Data were collected on age, age at diagnosis and CF
genotype from 29,025 CF patients registered in 35 Eur-
opean countries. Median age was 16.3 years but was
~4.9 years older in EU countries (17.0 years) than non-
EU countries (12.1 years; p<0.001; CI for the difference
was 4-5.1 years, a significant difference (OR 2.4, 95% CI
1.9 - 3.0). Under-ascertainment was unlikely because the
relative paucity of F508del-homozygous patients outside
the EU was also significant (95% present clinically in
childhood). We estimate that the current CF population
of non-EU countries would rise by 84% if they had a CF
demographic profile comparable to those of the EU
countries who were already EU members in 2003.
Interpretation
Given that neither the CF carrier frequency nor the rela-
tive territorial population size is significantly different
between the EU and non-EU participants, the reasons
for this apparent deficit in CF patients of a common
genotype in non-EU countries require explanation. It
may be that under diagnosis and premature childhood
mortality are the main drivers of the relative paucity of
CF in non EU states.
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